•
Mar 31, 2022

Parker-Hannifin Q3 2022 Earnings Report

Reported record sales and increased adjusted EPS guidance.

Key Takeaways

Parker-Hannifin reported record third-quarter sales of $4.09 billion, a 9% increase from the previous year. Adjusted earnings per share increased by 17% to a record $4.83. The company has updated its fiscal year 2022 adjusted EPS guidance to $18.00 to $18.30.

Sales increased 9% to $4.09 billion, with organic sales up 11%.

Segment operating margin was 20.3% as reported, or 22.7% adjusted.

Adjusted segment operating margin increased 130 bps vs. prior year.

EPS were $2.67 as reported, or $4.83 adjusted.

Total Revenue
$4.09B
Previous year: $3.75B
+9.1%
EPS
$4.83
Previous year: $4.11
+17.5%
Organic Sales Growth
11.1%
Gross Profit
$1.16B
Previous year: $1.03B
+12.3%
Cash and Equivalents
$468M
Previous year: $490M
-4.5%
Free Cash Flow
$490M
Previous year: $484M
+1.1%
Total Assets
$22.5B
Previous year: $19.8B
+13.6%

Parker-Hannifin

Parker-Hannifin

Parker-Hannifin Revenue by Segment

Forward Guidance

For the fiscal year ending June 30, 2022, the company has updated guidance for earnings per share to the range of $13.00 to $13.30, or $18.00 to $18.30 on an adjusted basis. Guidance assumes organic sales growth of approximately 11% compared with the prior year. COVID-19 related shutdowns in China are estimated to reduce sales by $100 million and EPS by $0.24 in the fourth quarter.

Positive Outlook

  • Expect to finish the year with a record level of financial performance.
  • Solid foundation to achieve new five-year targets for fiscal year 2027.
  • Continued progress being made towards meeting all the conditions required to complete the Meggitt acquisition.
  • Ongoing transformation of our portfolio.
  • Strong alignment with the positive secular trends of aerospace, digital, electrification and clean technologies.

Challenges Ahead

  • Supply chain pressures.
  • Labor pressures.
  • Inflationary pressures.
  • COVID-19 related shutdowns in China are estimated to reduce sales by $100 million in the fourth quarter.
  • COVID-19 related shutdowns in China are estimated to reduce EPS by $0.24 in the fourth quarter.